Cited by 11Kawasaki Disease and Coronary ComplicationsVasculitis and related conditionsArtificial Intelligence in Healthcare and Education

Applications of artificial intelligence in vasculitides: a systematic review

Open access
Omar, Mahmud, Agbareia, Reem, Naffaa, Mohammad E., Watad, Abdulla, Glicksberg, Benjamin S., Nadkarni, Girish N., Klang, Eyal·2025·ACR Open Rheumatology

Published version of a preprint

Abstract

OBJECTIVE: Vasculitides are rare inflammatory disorders that sometimes can be difficult to diagnose due to their diverse presentations. This review examines the use of artificial intelligence (AI) to improve diagnosis and outcome prediction in vasculitis. METHODS: A systematic search of PubMed, Embase, Web of Science, Institute of Electrical and Electronics Engineers Xplore, and Scopus identified relevant studies from 2000 to 2024. AI applications were categorized by data type (clinical, imaging, textual) and by task (diagnosis or prediction). Studies were assessed for risk of bias using the Prediction Model Risk of Bias Assessment Tool and Quality Assessment of Diagnostic Accuracy Studies-2. RESULTS: A total of 46 studies were included. AI models achieved high diagnostic performance in Kawasaki disease, with sensitivities up to 92.5% and specificities up to 97.3%. Predictive models for complications, such as intravenous Ig resistance in Kawasaki disease, showed areas under the curves between 0.716 and 0.834. Other vasculitis types, especially those using imaging data, were less studied and often limited by small datasets. CONCLUSION: The current literature shows that AI algorithms can enhance vasculitis diagnosis and prediction, with deep- and machine-learning models showing promise in Kawasaki disease. However, broader datasets, more external validation, and the integration of newer models like large language models are needed to advance their clinical applicability across different vasculitis types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acr2.70016

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Isolated studies aim to leverage AI to classify inflammatory dermatoses or advance disease understanding with immunophenotyping, and newer AI models including deep learning and generative AI applications are underutilized.

    “Isolated studies aim to leverage AI to classify inflammatory dermatoses or advance disease understanding with immunophenotyping. Newer AI models, including deep learning and generative AI applications, are underutilized (Omar et al, 2025).”

    From Artificial intelligence–enabled precision medicine for inflammatory skin diseases (2026) · cites this paper as Omar et al, 2025

    The Discussion (page unavailable) says newer models such as large language models have not been explored in vasculitis, supporting a gap in generative-AI applications. But the Results report existing deep-learning studies, and the paper addresses vasculitis rather than classification of inflammatory dermatoses or immunophenotyping. It does not support those parts of the claim or establish that deep learning is underutilized. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • An AI model achieved high diagnostic performance for predicting Kawasaki disease and intravenous Ig resistance from health data.

    “Among vasculitides, an AI model achieved high diagnostic performance for predicting Kawasaki disease and intravenous Ig resistance from health data (Omar et al, 2025)”

    From Artificial intelligence–enabled precision medicine for inflammatory skin diseases (2026) · cites this paper as Omar et al, 2025

    The Discussion (page unavailable) reports strong performance for models diagnosing Kawasaki disease from clinical and laboratory data and for other models predicting intravenous Ig resistance. It does not report that a single model performed both tasks, as the citing sentence implies. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [31]Siewert B, Błaszczyński J, Gowin E, et al. Can AI help pediatricians? Diagnosing Kawasaki disease using DRSA. Children (Basel) 2021; 8: 929. 34682194 PMC8534704

Cited by

Sorted by citations

Authors
Omar, M., Agbareia, R., Naffaa, M. E., Watad, A., Glicksberg, B. S., Nadkarni, G. N., & Klang, E.
Affiliations
  • Maccabi Healthcare Services (IL)
  • Hadassah Medical Center (IL)
  • Western Galilee Hospital (IL)
  • Sheba Medical Center (IL)
  • Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Omar, Mahmud
Venue
ACR Open Rheumatology
Publisher
Wiley
Published
2025-03
Volume
7
Issue
3
Pages
e70016-e70016
ISSN
2578-5745 (ISSN-L)
OpenAlex
W4408499704
Cited by
11
References
76
Citations by year
2026: 9 · 2025: 2
FWCI
2.66
Type
journal article
Language
en
Open access
Locations
  • ACR Open Rheumatology (publishedVersion, cc-by-nc-nd)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Surgery › Kawasaki Disease and Coronary Complications
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vasculitis and related conditions
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
vasculitis, artificial intelligence, Kawasaki disease, vasculitis diagnosis, outcome prediction, intravenous immunoglobulin resistance, deep learning, machine learning, large language models, diagnostic accuracy, inflammatory diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review